Go back

Fusion and medicines projects downplay auditors’ concerns

Two large public-private partnerships have said that red flags raised about their operations by the European Court of Auditors should not be a cause for concern.

The auditors said in their report on the EU’s contribution to the international nuclear fusion energy project Iter, published on 12 November, that “there remains a risk of further cost increases and delays in project implementation”.

The project has already been delayed by 15 years and its construction costs have increased by more than €5 billion (82 per cent) compared with the original 2010 estimates. It is now estimated that construction will be complete by 2035, with the milestone of first plasma acheived by the end of 2025.

This article on Research Professional News is only available to Research Professional or Pivot-RP users.

Research Professional users can log in and view the article via this link

Pivot-RP users can log in and view the article via this link.